Related Experiment Video
Updated: May 26, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Variability in drug formularies and implications in decision support.
Matthew J Stephens1, John T Finnell, Linas Simonaitis
1Regenstrief Institute, Indianapolis, IN, USA.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|December 24, 2011
Summary
Physician prescription choices are hindered by highly variable formularies. Simplifying formulary composition can improve cost-effective prescribing and physician decision support.
Area of Science:
- Health Economics
- Clinical Pharmacy
- Healthcare Management
Background:
- Formularies significantly influence medication prescribing and patient costs.
- Variability in formularies complicates physician decision-making for cost-effective drug selection.
Purpose of the Study:
- To analyze the composition of 3,346 formularies.
- To assess outpatient prescription coverage, medication class diversity, and cost implications.
- To identify opportunities for formulary simplification.
Main Methods:
- Analysis of 3,346 unique formularies.
- Evaluation of prescription coverage and medication class distribution.
- Assessment of cost implications associated with formulary variations.
Main Results:
- 42% of analyzed formularies were found to be duplicative.
- Unique formularies exhibited significant variability in medications with minimal cost or usage impact.
- Complexity in formulary structure was identified as a barrier to cost-effective prescribing.
Conclusions:
- Formulary complexity and duplication can be substantially reduced.
- Simplification can lead to more intuitive decision support for physicians.
- Streamlined formularies may enhance the prescribing of cost-effective medications.
Related Concept Videos
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...